Guru Fundamental Report for HIMS

Validea's guru fundamental report indicates that HIMS & HERS HEALTH INC (HIMS) receives a 75% rating based on their Small-Cap Growth Investor model, which is based on the Motley Fool strategy. The rating is driven by strong fundamentals and price performance, with the report highlighting positive indicators such as profit margin, relative strength, and insider holdings; however, the analysis also points to failures in areas like cash and cash equivalents, the Fool Ratio, and sales.

Analysis

Hims & Hers Health Inc. (HIMS) has received a 75% rating from Validea's Small-Cap Growth Investor model, a framework based on Motley Fool's strategy, suggesting a moderate alignment with the model's criteria for growth investments, despite HIMS being classified as a large-cap entity in the Biotechnology & Drugs industry. This score, while approaching the 80% threshold Validea considers indicative of notable interest, reflects a mixed fundamental profile. HIMS demonstrated strengths by passing criteria for profit margin, relative stock price strength, year-over-year sales and EPS growth, insider holdings, cash flow from operations, profit margin consistency, R&D as a percentage of sales, inventory to sales, accounts receivable to sales, long-term debt/equity ratio, and its current price level. However, the company failed to meet the model's standards for cash and cash equivalents, "The Fool Ratio" (P/E to Growth), average shares outstanding, a specific "Sales" metric (which is distinct from the year-over-year sales growth comparison that it passed), daily dollar trading volume, and its income tax percentage. This combination of positive operational indicators and specific financial or valuation shortcomings warrants a balanced view.

Key Decisions for Investors

• Investors should acknowledge HIMS's positive operational trends, such as robust profit margins and growth in sales and EPS, but carefully weigh these against the identified weaknesses concerning its cash reserves, valuation based on the P/E to Growth ratio, and specific sales volume metrics.
• Given the 75% score from the growth-focused model is below Validea's 'strong interest' threshold of 90%, interested parties should conduct further due diligence on the failed criteria, particularly regarding cash management, share structure (average shares outstanding), and the absolute sales figures, before making investment decisions.
• Monitoring HIMS's cash and cash equivalents, trends in average shares outstanding, daily trading volume, and developments related to its income tax percentage will be important for assessing if the company is addressing these flagged areas or if they constitute persistent risks.